Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F
Natura:	Journal article
Lingua:	English
Pubblicazione:	Frontiers Media 2021

Documenti analoghi

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
di: Helen L. Stark, et al.
Pubblicazione: (2021-03-01)

An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
di: Alzhrani, AI
Pubblicazione: (2021)

Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
di: Honeyman, C, et al.
Pubblicazione: (2021)

Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
di: Honeyman, C, et al.
Pubblicazione: (2020)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
di: Maja-Theresa Dieterlen, et al.
Pubblicazione: (2021-08-01)

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
di: Harden, PN, et al.
Pubblicazione: (2020)

Regulatory immune cells in transplantation.
di: Wood, K, et al.
Pubblicazione: (2012)

When to refer adult patients with congenital heart disease for transplantation: Which criteria to use, which work-up?
di: Alexander Van De Bruaene, et al.
Pubblicazione: (2021-08-01)

The where and when of T cell regulation in transplantation.
di: Issa, F, et al.
Pubblicazione: (2013)

The where and when of T cell regulation in transplantation
di: Issa, F, et al.
Pubblicazione: (2013)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
di: Alzhrani, A, et al.
Pubblicazione: (2020)

Regulatory B cells in transplantation: roadmaps to clinic
di: Beckett, J, et al.
Pubblicazione: (2020)

Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy
di: Felix J. Hartmann, et al.
Pubblicazione: (2019-07-01)

DIGITAL PMMA, WHEN AND WHICH
di: Andreea Mariana Bănățeanu, et al.
Pubblicazione: (2024-12-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
di: Hyeyoung Lee, et al.
Pubblicazione: (2017-01-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
di: Dominika Deborska-Materkowska, et al.
Pubblicazione: (2018-04-01)

Deciphering the contribution of γδ T cells to outcomes in transplantation
di: McCallion, O, et al.
Pubblicazione: (2018)

The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?
di: Jacobson PK, et al.
Pubblicazione: (2023-07-01)

A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection
di: Kaminski, Michael M., et al.
Pubblicazione: (2020)

Evaluation of Minitubers Yield and Scaling which Produced from Microtubers Transplanting Using Soilless Culture Technique
di: Falah Hassan Issa
Pubblicazione: (2017-06-01)

Cerebrovascular neuroimaging: Which tests and when?
di: Michael Hoffmann
Pubblicazione: (1996-09-01)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
di: Wright, S, et al.
Pubblicazione: (2021)

Opportunities for high-plex spatial transcriptomics in solid organ transplantation
di: Cross, AR, et al.
Pubblicazione: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
di: Nicola Personeni, et al.
Pubblicazione: (2020-03-01)

Towards regulatory cellular therapies in solid organ transplantation
di: Bottomley, MJ, et al.
Pubblicazione: (2021)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
di: Brook, MO, et al.
Pubblicazione: (2024)

Infections in transplant “Bugs which bug transplantation in India”
di: Manisha Sahay
Pubblicazione: (2017-01-01)

What moves where when in which languages?
di: Richards, Norvin W. (Norvin Waldemar), 1971-
Pubblicazione: (2008)

Investigations in West Syndrome: Which, When and Why
di: Richard E Appleton
Pubblicazione: (2015-06-01)

Characterising the immune response to combined skin and solid organ transplants
di: Stark, H
Pubblicazione: (2022)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
di: Antje R. Weseler, et al.
Pubblicazione: (2023-05-01)

IL‐33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
di: Kawai, K, et al.
Pubblicazione: (2020)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
di: Carroll, R, et al.
Pubblicazione: (2013)

Imaging the cellular components of the immune system for advancing diagnosis and immunotherapy of cancers
di: K. Bhise, et al.
Pubblicazione: (2021-06-01)

Extracorporial Knots in Laparoscopic Surgery: Which, When, and How
di: Omar Salem Khattab
Pubblicazione: (2008-10-01)

Alternatives to norepinephrine in septic shock: Which agents and when?
di: Mathieu Jozwiak
Pubblicazione: (2022-10-01)

Which Test to Perform for Cystic hydatic Diagnosis and When?
di: Zahra Arab-Mazar, et al.
Pubblicazione: (2020-06-01)

When will European Muslim population be majority and in which country?
di: Pierre Rostan, et al.
Pubblicazione: (2020-09-01)

Stent for Crohn’s disease strictures: Which one and when?
di: Alain Attar
Pubblicazione: (2016-03-01)

Blood component therapy: Which, when and how much
di: Rajesh Chand Arya, et al.
Pubblicazione: (2011-01-01)